ART6043 + Olaparib for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Jun 2023: Trial registered, NCT05898399
  2. 30 Jun 2023: Trial started, NCT05898399

The trials

NCT05898399: Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

State
Under way
Phase
Phase 1 and Phase 2
People
181 planned
Started
30 Jun 2023
Primary completion
30 Jun 2028
Arms
Part A2 (ART6043 in combination with olaparib), Part B2 (ART6043 in combination with olaparib)
Results
None posted
  1. 12 Jun 2023: Trial registered
  2. 30 Jun 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.